Article
Telomerase and breast cancer
1 Jun 2001
Abstract excerpt
Current therapies for breast cancer include treatments that are toxic and often result in drug resistance. Telomerase, a cellular reverse transcriptase that maintains the ends of chromosomes (telomeres), is activated in the vast majority of breast cancers (over 90% of breast carcinomas) but not in normal adjacent tissues. Telomerase is thus an attractive target for both diagnosis and therapy because of its...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.